查看PDF原文 公告日期：2016-03-22 　　上海医药(02607) 5-year guidance looks ambitious Shanghai Pharmaceuticals (SPH) reported 4Q15 revenue/core EPS ofRMB54.6bn/0.19, representing 11.8%/4.7% YoY growth, vs. 15%/20% in 9M15.We attribute the growth deceleration in 4Q15 to a sector slowdown.Mana...